Tevogen TVGN
NASDAQ TVGN
$6.72 +0.10 (+1.51%)
As of: Oct 1, 2026 · 3:26 PM EDT

Tevogen (TVGN) Cash from Restructuring (2024)

Updated

Tevogen (TVGN) posted Cash from Restructuring of $7.1 million for FY2024.

Analysis

Tevogen (TVGN) Cash from Restructuring (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Tevogen 27.60 Mn 24.63 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 7.10 Mn
API Access

Tevogen Cash from Restructuring API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-restructuring&ticker=TVGN&period=max&api_key=YOUR_API_KEY